SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Labwire Inc. -- Ignore unavailable to you. Want to Upgrade?

To: creede who wrote (1400)1/5/2009 1:01:50 AM
From: rogerover1 Recommendation  Read Replies (2) | Respond to of 1698
 
What are the revenues from these contracts expected to be? Best case, most likely, and worst case, if you can estimate. And what will the profit margins be? I just don't quite see how the business is that profitable.

How many shares out are there now, fully diluted? Will they need to sell more shares to raise funds to be able to staff up to service the contracts? Thanks.



To: creede who wrote (1400)1/5/2009 3:32:41 PM
From: rogerover2 Recommendations  Read Replies (1) | Respond to of 1698
 
What will Labwire's contract with Aramark bring in? Revenues and profits.

Sorry to keep asking the same pesky practical questions, but this is why your stock is trading at under a dime.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News